Ursodeoxycholic acid

熊去氧胆酸

Report date: 2026/03/20 20:03:07
NME

Base Information

Drug NameUrsodeoxycholic acid
Drug Alias Name解尔Ursolite解尔石LJDCAUDCA +[24] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionImmunosuppressantsImmunomodulatorsApoptosis inhibitors +[5] 
TargetsBile acid receptor FXRCholesterol
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Jaundice, ObstructiveChild Nutrition Disorders +[28] 
Global Approved IndicationsSteatorrheaCholecystolithiasisCholelithiasis +[5] 
Approved Indications in ChinaSteatorrheaCholelithiasis
Original Approved Country/TerritoryJapan
Original Approved Date1957/03/13
Country/TerritoryCanadaUnited StatesUganda +[18] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAllergan Plc
China Registration ClassN/A

Develop Information

Active CompaniesChangzhou Pharmaceutical FactoryUniversity Of MinnesotaUniversity Of Cambridge +[9] 
Inactive CompaniesRadboud University Medical CenterOregon Health And Science UniversityDr Falk Pharma GmbH +[19] 
Active IndicationsCoronavirus Disease 2019 (COVID-19)Child Nutrition DisordersHyperlipidemias +[14] 
Inactive IndicationsJaundice, ObstructiveGlucose IntoleranceHeart Failure +[14] 

Other Information

ATC CodeA05AA02
Related LinksWikipediaDrugBankKEGG